We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
-8.31%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$9.35B
AUM Growth
+$1.57B
Cap. Flow
+$2.42B
Cap. Flow %
25.92%
Top 10 Hldgs %
31.61%
Holding
370
New
10
Increased
144
Reduced
147
Closed
31

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$109M
2
MSFT icon
Microsoft
MSFT
+$108M
3
CSCO icon
Cisco
CSCO
+$104M
4
NEE icon
NextEra Energy
NEE
+$102M
5
TXN icon
Texas Instruments
TXN
+$87.5M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$23M
2
VTR icon
Ventas
VTR
+$15.8M
3
PG icon
Procter & Gamble
PG
+$5.57M
4
ROP icon
Roper Technologies
ROP
+$4.51M
5
FAST icon
Fastenal
FAST
+$3.9M

Sector Composition

Rank Sector Weight
1 Technology 19.29%
2 Healthcare 18.06%
3 Financials 14.08%
4 Industrials 10.05%
5 Consumer Staples 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
151
Walmart Inc
WMT
$894B
$3.17M 0.03%
102,042
-927
-0.9% -$29.7K
EFA icon
152
iShares MSCI EAFE ETF
EFA
$79.4B
$3.13M 0.03%
53,212
-2
-0% -$125
OKE icon
153
Oneok
OKE
$55B
$3.12M 0.03%
57,886
-1,170
-2% -$72.7K
LFUS icon
154
Littelfuse
LFUS
$11.7B
$3.03M 0.03%
17,681
-1,558
-8% -$278K
MCHP icon
155
Microchip Technology
MCHP
$42.2B
$3.02M 0.03%
84,120
GWW icon
156
W.W. Grainger
GWW
$60.7B
$2.96M 0.03%
10,499
+17
+0.2% +$5.06K
PACW
157
DELISTED
PacWest Bancorp
PACW
$2.95M 0.03%
88,608
+12,415
+16% +$495K
ELS icon
158
Equity Lifestyle Properties
ELS
$12.6B
$2.94M 0.03%
60,640
+18,480
+44% +$894K
KMB icon
159
Kimberly-Clark
KMB
$37.3B
$2.94M 0.03%
25,826
-6,331
-20% -$703K
DEO icon
160
Diageo
DEO
$49.2B
$2.93M 0.03%
20,657
-790
-4% -$111K
SMG icon
161
ScottsMiracle-Gro
SMG
$3.85B
$2.82M 0.03%
45,827
+20,572
+81% +$1.46M
USPH icon
162
US Physical Therapy
USPH
$1.18B
$2.8M 0.03%
27,363
-2,062
-7% -$229K
RBA icon
163
RB Global
RBA
$17.8B
$2.75M 0.03%
84,176
-6,837
-8% -$230K
NI icon
164
NiSource
NI
$20.6B
$2.73M 0.03%
107,687
+22,884
+27% +$590K
BX icon
165
Blackstone
BX
$109B
$2.71M 0.03%
91,004
+3,900
+4% +$129K
FLO icon
166
Flowers Foods
FLO
$1.57B
$2.7M 0.03%
146,113
+54,293
+59% +$1.04M
MLAB icon
167
Mesa Laboratories
MLAB
$574M
$2.67M 0.03%
12,833
-953
-7% -$186K
STE icon
168
Steris
STE
$22.7B
$2.67M 0.03%
24,954
-1,420
-5% -$159K
DUK icon
169
Duke Energy
DUK
$96.2B
$2.65M 0.03%
30,704
+563
+2% +$47.9K
PAHC icon
170
Phibro Animal Health
PAHC
$1.46B
$2.63M 0.03%
81,804
+2,646
+3% +$99.8K
SIX
171
DELISTED
Six Flags Entertainment Corp.
SIX
$2.63M 0.03%
47,293
+17,066
+56% +$1.02M
MDSO
172
DELISTED
Medidata Solutions, Inc.
MDSO
$2.6M 0.03%
38,566
-2,971
-7% -$210K
CVGW
173
DELISTED
Calavo Growers
CVGW
$2.6M 0.03%
35,625
-2,884
-7% -$269K
TYPE
174
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$2.57M 0.03%
165,786
+29,763
+22% +$530K
JBTM
175
JBT Marel
JBTM
$6.35B
$2.56M 0.03%
35,690
+811
+2% +$71.9K

Similar funds

Bahl & Gaynor's Q4 2018 Portfolio in Review

As of Q4 2018, Bahl & Gaynor held 370 positions worth $9.35B, up 20% from $7.78B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor deployed $2.42B of net new capital in Q4 2018, opening 10 new positions and adding to 144 existing holdings. Its largest new stake was Celanese: 21,191 shares worth $1.91M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ventas, an estimated $15.8M trimmed.

  • Bahl & Gaynor's largest Q4 2018 buy was Celanese: 21,191 shares worth $1.91M.
  • Bahl & Gaynor added most to JPMorgan Chase in Q4 2018, an estimated $109M increase.
  • Bahl & Gaynor's biggest Q4 2018 reduction was Ventas, cutting an estimated $15.8M.
  • Bahl & Gaynor fully exited Praxair Inc in Q4 2018, selling an estimated $23M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $9.35B portfolio in Q4 2018.
  • Bahl & Gaynor opened 10 new positions and closed 31 in Q4 2018.
  • Bahl & Gaynor's portfolio value rose 20% quarter-over-quarter to $9.35B.

Based on Bahl & Gaynor's 13F filing for Q4 2018, filed 12 Feb 2019.